Mannan-binding lectin and its role in innate immunity

Area of Science:

• Immunology
• Infectious Diseases
• Molecular Biology

Background:

• Mannan-binding lectin (MBL) is a key component of the innate immune system, acting as a plasma collectin.
• MBL binds microbial surfaces, activating complement via the lectin pathway and neutralizing pathogens.
• Individual MBL concentrations vary significantly, influencing susceptibility to infections.

Purpose of the Study:

• To review the physiological significance of MBL in innate immunity.
• To highlight the clinical relevance of MBL deficiency in various infections and chronic diseases.
• To discuss the therapeutic potential of MBL replacement and recombinant MBL.

Main Methods:

• Literature review of clinical studies and research on MBL function.
• Analysis of MBL's role in innate immunity and complement activation.
• Evaluation of MBL insufficiency as a risk factor for infections and its influence on chronic diseases.

Main Results:

• Low MBL levels are associated with increased vulnerability to infections, especially in infants and immunocompromised patients.
• MBL insufficiency is a significant risk factor for infections during chemotherapy and post-transplant immunosuppression.
• MBL influences the course of chronic conditions such as rheumatoid arthritis and cystic fibrosis.

Conclusions:

• MBL deficiency is physiologically relevant and a significant risk factor for infections.
• MBL replacement therapy and recombinant MBL show therapeutic promise.
• Further clinical trials are needed to confirm the physiological significance and therapeutic efficacy of MBL.